retatrutide clinical trial results 2024 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation ESC 2024: Retatrutide improves lipid

Evidence-Based Treatment Many top programs now offer GLP-1 medications such as: semaglutide tirzepatide Wegovy Zepbound These medications should only be prescribed after medical evaluation and provider review

Entity 3: Partner Compounding Pharmacies If a prescription is written, it is filled by one of the platform's partner compounding pharmacies, which the company identifies as Foothills Pharmacy and Promise Pharmacy

These divergent findings likely reflect heterogeneity in study design, mechanisms of action of the drugs evaluated, duration of follow-up, and the degree of metabolic phenotyping across populations

Semaglutide needs to be taken long-term to be effective for blood sugar management or weight loss

Energy can dip early in treatment

But federal regulators are warning consumers that compounded GLP-1s are not FDA-approved and may carry risks, including dosing errors